Journal Club: Prediction of Coronary Heart Disease Events in Blood or Marrow Transplantation Recipients
During this Journal Club, our esteemed faculty will explore the critical topic of predicting coronary heart disease events in blood or marrow transplantation recipients. Attending will allow healthcare professionals to improve patient care, make informed decisions and enhance outcomes for blood or marrow transplantation recipients in relation to coronary heart disease events.
The partnership combines Radcliffe’s rapidly growing global community and expertise in delivering the most innovative virtual events, with the knowledge and experience of IC-OS’s members, to curate broadcasts that challenge current practice and have real-world patient benefits.
This broadcast is for cardiologists, haematologists, oncologists, nurse practitioners, nurses and pharmacists.
The International Cardio-Oncology Society is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer therapy. By optimising the cardiac status of patients with cancer before, during and after their treatment, IC-OS is collectively improving the overall outcomes including survival and quality of life. IC-OS aims to provide the latest scientific and clinical education and research for anyone treating patients with cancer in the hopes of enhancing cardiovascular protection.
This is an independent activity run by the International cardio-oncology Society (ICOS) and co-produced in collaboration with Radcliffe Cardiology. IC-OS has been provided support to deliver this webinar series by AstraZeneca, BMS/Pfizer Alliance, Eli Lilly and Roche through an unrestricted educational grant to cover organisational costs and has had no input into the agenda or content of this educational activity. Radcliffe Cardiology has received no industry funding.
Patricia S de Marco
This broadcast is supported by
Prof Daniel Lenihan is a cardio-oncologist specialising in cardiology, heart disease and advanced heart failure, at Saint Francis Healthcare System, Cape Girardeau, US.
He is a co-Founder and Board Member of the International Cardio-Oncology Society (ICOS), which is an international professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy.
He is actively involved in patient care as the Director of the Cardio-Oncology Programme, Cardiac Rehabilitation, and the Heart Failure clinic at Saint Francis Healthcare System.
Prof Joe Carver is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, Philadelphia, US the Chief Operating Officer of the Abramson Family Cancer Research Institute and the Chief of Staff of the Abramson Cancer Center.
He is the Director of the Thalheimer Cardio-oncology Center at the Abramson Cancer Center and his clinical practice is in the subspecialty of cardio-oncology.
Patricia S de Marco
Dr de Marco is a cardiologist certified by the Brazilian Society of Cardiology. She is a fellow in Cardio-Oncology at the Brazilian Clinical Research Institute and Preceptor of the Internal Medicine department at Faculdade de Medicina de São José do Rio Preto.
Dr Jose Alvarez-Cardona is a Cardiologist and Assistant Professor at New York University School of Medicine, New York, US.
He received his medical degree from University of Puerto Rico School of Medicine. He specialises in cardiomyopathy and heart failure. His specialities include cardiac amyloidosis, cardiomyopathy and heart failure, congestive heart failure, heart transplant and left ventricular assist devices.
Dr Iskra Pusic is an Associate Professor at the Division of Oncology, Washington University School of Medicine in St. Louis, US.
Dr Pusic was educated at the University of Zagreb School of Medicine between 1991 - 1997, before completing her Obligatory Medical Traineeship from 1997 - 1998 at the University Hospital Center "Rebro". Following this Dr Pusic completed fellowships at the University of Nebraska Medical Center, State University of New York and Washington University School of Medicine.
Dr Pusic is a member of numerous professional societies and organisations, including the American Society of Hematology, Women Committee in American Society of Transplantation and Cellular Therapies, and the International Cardio-Oncology Society.
Her research interests focus on long-term complications after allogeneic hematopoietic cell transplantation, particularly Graft-versus-Host Disease (GvHD) and survivorship.